Ken Getz to Deliver Keynote Address at OpenClinica Global Conference

Share Article

Clinical R&D thought leader to discuss how open, integrated, and engaged communities hold tremendous promise for helping to support new models for clinical innovation.

News Image
The sustainability of drug development desperately depends on new models of innovation

Kenneth A. Getz, Chairman of the Center for Information & Study on Clinical Research Participation CISCRP, and Senior Research Fellow and Assistant Research Professor at the Tufts Center for the Study of Drug Development, will be the Keynote Speaker at this year’s OpenClinica Global Conference, May 8-9 at the Metro Meeting Centers—101 Federal St. in downtown Boston.

The OpenClinica Global Conference brings together users, developers, and other stakeholders from this community to share knowledge and best practices. The event features lectures, case studies, tutorials, panel discussions, posters, and technical demonstrations.

OpenClinica is the world’s most popular open source clinical trials software. It facilitates web-based electronic data capture (EDC) and clinical data management (CDM) in all types of clinical research across a diverse array of settings.

Mr. Getz’s keynote presentation, titled Driving Biopharmaceutical Innovation through Integrated and Open Communities, builds on his unique perspective as a recognized authority on drug development best practices and innovation. “The sustainability of drug development desperately depends on new models of innovation,” said Mr. Getz. “Open, integrated and engaged communities and projects hold tremendous promise for helping to address this need.”

Mr. Getz is known for his work studying drug R&D management practices; pharmaceutical and biotechnology company operating models; and global investigative site, outsourcing, and study volunteer practices, trends and policies. He is also the founder and owner of CenterWatch, a leading publisher in the clinical trials industry. Mr. Getz has authored two nationally recognized books on clinical trials and serves on the boards of the Institute of Medicine's Clinical Research Roundtable, the DIA Foundation, the Consortium to Examine Clinical Research Ethics, and the Clinical Trials Transformation Initiative. He is on the editorial boards of Contemporary Clinical Trials, Research Practitioner, and the Drug Information Journal and writes a bi-monthly column for Applied Clinical Trials.

More information about the OpenClinica Global Conference and the updated conference program is available online at: https://www.openclinicaconference.org.

About OpenClinica®

OpenClinica enhances the productivity of clinical trials through commercial open source software. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information – including product downloads – visit http://www.openclinica.com or follow @OpenClinica on Twitter.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Matt Ellis
Visit website